Standard Operating Procedure for Regulatory Intelligence Support to Product Lifecycle Strategy

Department	Regulatory Affairs
SOP No.	RA/2026/639
Supersedes	NA
Page No.	1 of X
Issue Date	09/04/2026
Effective Date	09/04/2026
Review Date	09/04/2028

Purpose

This Standard Operating Procedure (SOP) establishes a structured process for regulatory intelligence activities that support the product lifecycle strategy. It aims to ensure timely, accurate, and comprehensive collection, analysis, and dissemination of regulatory information to inform decision-making and maintain compliance. The SOP supports the control objective of proactive management of regulatory requirements to facilitate product registrations, renewals, compliance, and strategic planning within regulated environments.

Scope

This SOP applies to all regulatory intelligence activities performed within the Regulatory Affairs department, supporting any functional area, dosage form, regulatory process, and product lifecycle stage. It covers monitoring of regulatory policies, guidelines, and other relevant information sources at local, regional, and global levels. Activities excluded are intelligence tasks related to unrelated corporate functions and non-regulatory strategic planning outside product lifecycle considerations.

Responsibilities

The following roles are responsible for the execution and oversight of regulatory intelligence functions under this SOP:

• Regulatory Intelligence Analysts: Collect and analyze regulatory information.
• Regulatory Affairs Managers: Review and validate intelligence findings and approve dissemination.
• Quality Assurance: Monitor compliance with this SOP and support audit readiness.
• Document Control: Maintain version control and archival of intelligence reports and records.
• Regulatory Affairs Directors: Provide oversight and final authorization of intelligence strategy alignment.

Accountability

The Regulatory Affairs Head is accountable for the effective implementation, adherence, periodic review, escalation of issues, and continual improvement of this SOP. They ensure resources, training, and management support are available to maintain compliance and strategic alignment with evolving regulatory requirements.

Procedure

1. Preparation and Planning
Identify and document regulatory intelligence needs linked to ongoing product lifecycle projects. Establish key regulatory frameworks, jurisdictions, and topics relevant to products and markets served.

2. Information Collection
Perform systematic and ongoing monitoring of regulatory sources including databases, agency portals, industry publications, and global regulatory announcements. Utilize validated tools and subscriptions where applicable.

3. Data Screening and Filtering
Apply relevance and impact criteria to filter out non-pertinent information. Focus on regulatory changes, guidances, warnings, or updates that may influence product registrations, compliance, labeling, or market strategy.

4. Analysis and Interpretation
Evaluate the implications of identified regulatory intelligence. Determine impact on existing dossiers, submission strategies, product maintenance, labeling, or manufacturing requirements. Document risk assessments or opportunities arising from the intelligence.

5. Dissemination and Communication
Prepare standardized regulatory intelligence reports using template formats (see Annexure-1). Distribute reports to relevant stakeholders including project teams, regulatory project managers, quality, compliance, and leadership in a timely manner. Ensure secure and controlled dissemination.

6. Documentation and Record Keeping
Maintain all regulatory intelligence reports, source data, and analysis records in controlled repositories to ensure traceability and audit readiness. Follow document control procedures for review, approval, version control, and archival.

7. Review and Update
Periodically review the regulatory intelligence process for effectiveness. Update monitoring sources, criteria, and documentation templates as required to remain current with evolving regulatory landscapes.

8. Deviation Handling
Identify and document deviations from this SOP. Assess impact and initiate corrective and preventive actions in compliance with the quality system.

9. Training and Competency
Ensure all personnel engaged in regulatory intelligence activities receive initial and ongoing training on this SOP, regulatory requirements, and data analysis techniques.

This procedure enables regulatory affairs teams to proactively support product lifecycle management by integrating accurate and timely regulatory inputs into strategic decision-making processes within a controlled and compliant framework.

Abbreviations

GMP: Good Manufacturing Practice
SOP: Standard Operating Procedure
RA: Regulatory Affairs
QA: Quality Assurance
API: Active Pharmaceutical Ingredient

Documents

1. Regulatory Intelligence Report Template (Annexure-1)
2. Regulatory Change Impact Assessment Form (Annexure-2)
3. Regulatory Intelligence Monitoring Log (Annexure-3)

References

ICH Q10 Pharmaceutical Quality System, FDA Guidance Documents on Regulatory Intelligence, EMEA Data Protection Guidelines, ISO 9001:2015 Quality Management Systems, Local and International Regulatory Agency Guidelines, Internal Document Control Procedure.

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Regulatory Intelligence Report Template

Purpose: To standardize the collection and reporting of regulatory intelligence findings impacting product lifecycle activities.

Report ID	RI-2026-001
Date	10/04/2026
Prepared By	Regulatory Intelligence Analyst
Regulatory Source	FDA Guidance Portal
Jurisdiction	United States
Product(s) Impacted	Product A (API), Product B (Finished Dosage Form)
Summary of Change	Updated labeling requirements for stability data submission effective 01/07/2026.
Impact Assessment	Requires amendment to existing product dossiers and submission timelines.
Recommended Actions	Initiate dossier update planning with cross-functional teams and submit revised documentation by 15/06/2026.
Distribution List	Regulatory Project Managers, Quality Assurance, Manufacturing
Comments	Monitor further guidance updates related to excipient changes.

Annexure-2: Regulatory Change Impact Assessment Form

Purpose: To document the detailed impact evaluation of regulatory changes on product lifecycle and compliance strategy.

Assessment ID	RCA-2026-011
Date	11/04/2026
Completed By	Regulatory Affairs Manager
Regulatory Change Description	Introduction of new stability testing requirements for oral solid dosage forms.
Products Affected	Product C, Product D
Process Impact	Revision of stability protocols and validation criteria required.
Timeline for Compliance	31/08/2026
Cross-Functional Teams Involved	Analytical Development, Quality Control, Manufacturing
Risk Assessment	Medium risk of delayed product release if not implemented timely.
Review Comments	Coordination with production needed to align schedules.
Approval Status	Pending

Annexure-3: Regulatory Intelligence Monitoring Log

Purpose: To maintain a comprehensive log of all monitored regulatory intelligence activities to ensure systematic tracking and audit readiness.

Date Monitored	Source	Regulatory Topic	Jurisdiction	Summary	Follow-up Actions	Status
10/04/2026	EMA News	New GMP Annex on Cleaning Validation	European Union	Draft guidance on enhanced cleaning validation expectations.	Review draft and prepare comments by 25/04/2026.	In Progress
08/04/2026	Health Canada	Product Labeling Update	Canada	Requirements for allergen declaration in packaging.	Update labeling SOP and notify manufacturing.	Completed
05/04/2026	FDA Press Release	New Process Validation Guidance	United States	Draft guidance focusing on Continuous Process Verification (CPV).	Assess impact on current validation protocols.	Pending

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
09/04/2026	1.0	Initial issue	New SOP creation